Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-22-000136
Filing Date
2022-12-07
Accepted
2022-12-07 18:43:26
Documents
1
Period of Report
2022-12-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3426
  Complete submission text file 0001765581-22-000136.txt   4974
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 221451123